Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?
作者信息
Scheiner M A, Kimmel S E
出版信息
J Gen Intern Med. 1997 Sep;12(9):581-2. doi: 10.1046/j.1525-1497.1997.07147.x.
Abstract
摘要
相似文献
1
Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?心力衰竭与血管紧张素转换酶抑制剂。是否需要专科护理？
J Gen Intern Med. 1997 Sep;12(9):581-2. doi: 10.1046/j.1525-1497.1997.07147.x.
2
Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics.血管紧张素转换酶抑制剂在心力衰竭治疗中的应用与剂量。医师专业和患者特征的影响。
J Gen Intern Med. 1997 Sep;12(9):563-6. doi: 10.1046/j.1525-1497.1997.07110.x.
3
Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?为什么全科医生在心力衰竭治疗中对血管紧张素转换酶抑制剂的使用不足？
Int J Cardiol. 1997 Mar;59(1):7-10. doi: 10.1016/s0167-5273(96)02904-x.
4
Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.全科医生和专科医生在充血性心力衰竭中使用血管紧张素转换酶抑制剂的知识及应用方面的差异。
J Gen Intern Med. 1997 Sep;12(9):523-30. doi: 10.1046/j.1525-1497.1997.07105.x.
5
Specialized heart failure centers--a success or an indicator of the failure of our health care delivery system.专业心力衰竭中心——是成功之举还是我们医疗服务体系失败的标志。
Clin Cardiol. 2000 Dec;23(12):881-2. doi: 10.1002/clc.4960231204.
6
Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction?心力衰竭的存在是否会改变心肌梗死后药物治疗的处方？
Med J Aust. 2007 Jan 15;186(2):99-100; author reply 100-101. doi: 10.5694/j.1326-5377.2007.tb00817.x.
7
Modern management of hypertension and heart failure: evidence and practice.高血压与心力衰竭的现代管理：证据与实践
Heart. 2000 Sep;84 Suppl 1(Suppl 1):i35-8; discussion i50. doi: 10.1136/heart.84.suppl_1.i35.
8
Diagnosis and management of heart failure: a questionnaire among general practitioners and cardiologists.心力衰竭的诊断与管理：一项针对全科医生和心脏病专家的问卷调查
Eur J Heart Fail. 2003 Jun;5(3):345-8. doi: 10.1016/s1388-9842(03)00049-7.
9
Angiotensin converting enzyme inhibition in heart failure: clinical trials and clinical practice.心力衰竭中的血管紧张素转换酶抑制：临床试验与临床实践
Cardiovasc Drugs Ther. 2002 Jan;16(1):67-74. doi: 10.1023/a:1015375717044.
10
Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.解释血管紧张素转换酶抑制剂在心力衰竭治疗中使用情况的医生、组织和患者特征：一项多层次研究。
Eur J Clin Pharmacol. 2005 Apr;61(2):145-51. doi: 10.1007/s00228-005-0897-6. Epub 2005 Mar 11.
引用本文的文献
1
Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: a retrospective, survey-weighted, cohort analysis.指南推荐的心脏药物在降低老年医疗保险心力衰竭人群死亡率方面的有效性：一项回顾性、调查加权的队列分析。
Drugs Aging. 2010 Oct 1;27(10):845-54. doi: 10.2165/11539340-000000000-00000.
本文引用的文献
1
Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics.血管紧张素转换酶抑制剂在心力衰竭治疗中的应用与剂量。医师专业和患者特征的影响。
J Gen Intern Med. 1997 Sep;12(9):563-6. doi: 10.1046/j.1525-1497.1997.07110.x.
2
Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.全科医生和专科医生在充血性心力衰竭中使用血管紧张素转换酶抑制剂的知识及应用方面的差异。
J Gen Intern Med. 1997 Sep;12(9):523-30. doi: 10.1046/j.1525-1497.1997.07105.x.
3
Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
J Am Coll Cardiol. 1996 Nov 1;28(5):1323-7. doi: 10.1016/S0735-1097(96)00301-4.
4
Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators.心力衰竭的自然病史及当前治疗模式。左心室功能障碍研究（SOLVD）调查组。
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):14A-19A. doi: 10.1016/0735-1097(93)90456-b.
5
Patterns of medication use in patients with heart failure: a report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD).
South Med J. 1995 May;88(5):514-23. doi: 10.1097/00007611-199505000-00002.
6
Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure).心力衰竭评估与管理指南。美国心脏病学会/美国心脏协会实践指南工作组（心力衰竭评估与管理委员会）报告。
J Am Coll Cardiol. 1995 Nov 1;26(5):1376-98.
7
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.依那普利对左心室射血分数降低的充血性心力衰竭患者生存率的影响。
N Engl J Med. 1991 Aug 1;325(5):293-302. doi: 10.1056/NEJM199108013250501.
8
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.依那普利对左心室射血分数降低的无症状患者死亡率及心力衰竭发生的影响。
N Engl J Med. 1992 Sep 3;327(10):685-91. doi: 10.1056/NEJM199209033271003.
9
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.卡托普利对心肌梗死后左心室功能不全患者死亡率和发病率的影响。生存与心室扩大试验的结果。SAVE研究人员。
N Engl J Med. 1992 Sep 3;327(10):669-77. doi: 10.1056/NEJM199209033271001.
Zotero 插件